Delivery Order SPE2DB22D3501-SPE2DB25FXH75
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 30, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Calquence 100 mg tablets (60-count) valued at $5,593.77. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 30, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $5,593.77, with completion expected by April 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (quantity 60) on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Calquence is a pharmaceutical product used in the treatment of hematologic...
- The Defense Logistics Agency awarded a $11,187.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Calquence 100 mg tablets (60 count) with a ceiling value of $5,593.77. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by September 12, 2025. The award leverages AmerisourceBergen's position as a prime contractor under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $11,187.56. The award was made on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Calquence 100 mg tablets (60-count units) valued at $11,187.56. This firm fixed-price delivery order, which is expected to be completed by August 8, 2025, represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the vendor's corporate office in Conshohocken,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXH75Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed price contract valued at $11,187.56, with completion expected by October 6, 2025. This non-set-aside award reflects competitive procurement and represents a small-value delivery order within AmerisourceBergen's broader relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. That prime vehicle serves as a comprehensive global pharmaceutical support contract enabling the company to supply medications, vaccines, and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The Calquence order supports the DLA Medical Supply Chain's mission to provide critical pharmaceutical products to federal healthcare systems, with Calquence being an oncology medication used in cancer treatment protocols.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/15/25 |